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RLETTER TO THE EDITOR
An  uncommon  association:  Chicken
pox and  Guillain—Barre  syndrome
Dear Editor,
Chickenpox  may  cause  neurological  complica-
tions such  as  meningitis,  meningoencephalitis  and
cerebellitis.  Guillain—Barre  syndrome  (GBS)  is a
rare but  severe  neurological  complication  of  chick-
enpox that  can  cause  sequela  [1].
A four-year-old  girl  with  typical  varicella  lesions
was admitted  to  our  clinic  with  leg  pain  and  dif-
ﬁculty  walking.  She  was  not  vaccinated  against
varicella, and  her  sister  had  experienced  chick-
enpox 20  days  prior.  The  following  neurologic
pathologies  were  found:  neck  stiffness,  meningeal
irritation signs,  muscle  strength  1—2/5,  areﬂexia
and ﬂexor  plantar  response.  Examinations  of  the
patient’s  other  systems  were  normal.  The  labo-
ratory  ﬁndings  were  as  follows:  normal  complete
blood count,  CRP  negative,  erythrocyte  sedimen-
tation rate  of  16  mm/h,  creatine  kinase  level
of 130  IU/ml  (50—190)  and  VZV  IgM  positive.
The brain  magnetic  resonance  imaging  was  nor-
mal, and  the  electromyography  (EMG)  showed
acute inﬂammatory  demyelinating  polyneuropathy
(AIDP). A  lumbar  puncture  could  not  be  per-
formed because  of  skin  lesions.  Ceftriaxone  and
acyclovir  were  administered.  Intravenous  immun-
globulin  (IVIG)  was  given  for  ﬁve  days  at  a  dosage
of 0.4  mg/kg/day.  Paralysis  spread  to  the  patient’s
neck and  bulbar  muscles.  Seventy-two  hours  after
administering  IVIG,  neck  muscles  paralysis,  swal-
lowing  and  speech  began  to  improve.  On  day  14  of
hospitalization,  the  patient’s  muscle  strength  was
3—4/5, and  her  deep  tendon  reﬂexes  (DTRs)  were
areﬂexic.  The  patient  was  discharged  and  referred
to a  physical  therapy  and  rehabilitation  program.
Three months  later,  the  patient’s  muscle  strength
had improved  to  4—5/5,  and  DTRs  were  hypoac-
tive.
Neurological complications  are  one  of  the  most
common causes  of  hospitalization  in  patients  with
[
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1876-0341/© 2014 King Saud Bin Abdulaziz University for Health Sciearicella  infection.  The  typically  emerge  in  patients
nder  ﬁve  years  of  age  or  over  20  years  of  age  espe-
ially two  to  six  days  after  the  rash  ﬁrst  develops.
omplications are  thought  to  be  due  to  viral  inva-
ion and  immune-mediated  allergic  mechanisms.
BS is  reported  in  the  elderly  and  people  with
ellular immune  system  deﬁciency  rather  than  in
hildren [2,3].
It  has  been  proposed  that  viruses  and  bacte-
ia trigger  the  immune  system  against  the  myelin
heath  resulting  in  the  pathogenesis  of  GBS.  In
atients with  AIDP,  the  cellular  immune  system  is
ctivated: however,  the  humoral  immune  systems
lay  a role  in  the  pathogenesis  of  other  subtypes  of
BS [4,5]. Our  patient’s  electrophysiological  ﬁnd-
ngs favored  the  diagnosis  of  AIDP,  and  she  did
ot show  humoral  immunodeﬁciency.  Thus,  in  this
ase, GBS  occurred  through  a  parainfectious  cellu-
ar immune  mediated  mechanism.
The varicella  vaccine  became  licensed  in  1995
nd led  to  a signiﬁcant  reduction  in  the  incidence
f varicella  in all  age  groups,  in  the  rate  of  hospi-
alization due  to  varicella  and  in  complications  of
aricella infections  [2]. Considering  the  contagious
ature of  the  disease,  the  cost  of  treatment  and  the
ccurrence  of  neurologic  sequelae  and  mortality,
e believe  that  national  immunization  programs
n developing  countries  should  administer  the  vari-
ella vaccine.
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